Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,721.20
(
0.00%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
105.71
(
1.23%
)
Bitcoin
71,073.99
(
1.68%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 97
Posts 38504
Boards Moderated 89
Alias Born 03/22/2005

gfp927z

Re: DewDiligence post# 54415

Tuesday, 11/06/2007 5:30:47 PM

Tuesday, November 06, 2007 5:30:47 PM

Post# of 257262
Thanks Dew. Any thoughts on how intense the competition might be from Schering's boceprevir? It doesn't have the rash side effect, and is only around 6 months or less behind telaprevir. Any idea how boceprevir's efficacy may compare to telaprevir? Thanks.





Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now